Obtenga las últimas noticias sobre las acciones de Pfizer con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de PFE

Últimas noticias sobre

PFIZER INC

Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Usa,President,Donald,Trump,On,Smartphone,And,Stock,Image,In

Analyst Color

Government

Regulations

Sector ETFs

Health Care

ETFs

BIIB

MRNA

TECH

El acuerdo de Trump con Pfizer impulsa las acciones del sector sanitario y marca un precedente en precios de medicamentos en EE.UU.Etiquetas:

Acciones del sector sanitario se disparan tras acuerdo Trump-Pfizer

Business,Development,,Financial,Plan,And,Strategy.analysis,Finance,Graph,And,Market

Equities

News

Markets

CRWV

Wall Street cerró en verde pese al inicio del cierre del gobierno en EE. UU. con movimientos destacados en NKE, PFE, CRWV, LAC y OXY.

Lithium Americas, Nike, Pfizer, CoreWeave, Occidental: 5 valores que están en el radar de los inversores

Logo,Pfizer,Inc.,Is,An,American,Multinational,Pharmacological,And,Biotechnology

Movers

Pfizer pacta con la Casa Blanca bajar precios de fármacos en Medicaid. El anuncio impulsa las acciones de la farmacéutica en Wall Street.

Las acciones de Pfizer (PFE) están subiendo el martes: ¿qué está pasando?

Pfizer Inc

Innovator U.S. Equity Power Buffer ETF - February

PFEIFFER VACUUM TECH ORD by Pfeiffer Vacuum Technology AG

Pfeiffer Vacuum Technology AG

Press Releases

Top 20 Companies Recognized in Labrador Transparency's 2025 U.S. Transparency Awards

General

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio

Legal

Johnson Fistel Investigates Fairness of Proposed Sale of Metsera

Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts

METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR

Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025

Hearing Against Pfizer Set For 29 September In Contraceptive 'Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio

Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients

Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025

ALPMY

ARVN

CTSH

INTU

MDLZ

MTSR

TYO:4503

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

B of A Securities

Citigroup

Morgan Stanley

Cantor Fitzgerald

Screenshot 2025-09-08 at 3.59.27 PM

Biotech

BDRX

RXRX

Tempest Therapeutics, Inc. - Common Stock

TPST

Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled

Screenshot 2025-06-17 at 8.31.13 PM

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study

Untitled design - 2025-03-31T165341.547

TNXP

VRTX

Tonix&#39;s Experimental Non-Opioid Analgesic Treatment For Fibromyalgia Could Start Bringing Relief Later This Year

Screenshot 2025-02-24 at 11.35.34 PM

BRTX

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

Screenshot 2024-11-20 at 6.30.30 PM

BioRestorative Ends Q3 In &#39;Strong&#39; Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial

Screenshot 2024-11-13 at 11.54.41 PM

ABBV

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Screenshot 2024-09-30 at 9.13.36 PM

The Rush For Non-Addictive Painkillers To Counter The Opioid Crisis Puts Two Companies Closer To FDA Decisions

Screenshot 2024-07-10 at 9.08.28 PM

AXSM

A Redux Of The Lyrica-Cymbalta Fibromyalgia War Of The 2010s May Look More Like David Vs. Goliath

Screenshot 2024-03-13 at 5.45.52 PM

FDXTF

SHTDY

Nanotechnology&#39;s Promising Role In Fighting Infectious Diseases: Protecting Surfaces With FendX&#39;s Nanotechnology

Screenshot 2024-02-24 at 12.03.42 AM

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

Comments

Pfizer Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL